Chaime Orlev
Director of Finance/CFO chez KAMADA LTD.
Fortune : 66 044 $ au 31/03/2024
Profil
Chaime Orlev is currently the Chief Financial Officer at Kamada Ltd.
He previously held CFO positions at various companies including ICTS International NV, Gammacan International, Inc., Chiasma, Inc., Bioblast Pharma Ltd., Huntleigh USA Corp., Oramed Pharmaceuticals, Inc., and Solel Solar Systems Ltd.
Orlev received an undergraduate degree from The College of Management Academic Studies and an MBA from The Leon Recanati Graduate School of Business Administration.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KAMADA LTD
0,02% | 01/03/2024 | 11 633 ( 0,02% ) | 66 044 $ | 31/03/2024 |
Postes actifs de Chaime Orlev
| Sociétés | Poste | Début |
|---|---|---|
| KAMADA LTD. | Director of Finance/CFO | 31/12/2017 |
Anciens postes connus de Chaime Orlev
| Sociétés | Poste | Fin |
|---|---|---|
Bioblast Pharma Ltd.
 Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Director of Finance/CFO | 01/11/2017 |
| CHIASMA, INC. | Director of Finance/CFO | 10/06/2015 |
| ORAMED PHARMACEUTICALS INC. | Director of Finance/CFO | 01/01/2009 |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Director of Finance/CFO | 01/02/2008 |
Solel Solar Systems Ltd.
 Solel Solar Systems Ltd. Engineering & ConstructionIndustrial Services Solel Solar Systems Ltd. provides solar thermal power services. It designs, manufactures and installs turnkey solar fields for large scale power generation. It offers technology for new solar power plants in the US, Spain and other sun-rich locations. Solel's technology converts sunshine into useful thermal energy, and subsequently into electricity, by way of parabolic mirrors that concentrate the solar energy onto solar thermal receivers containing a heat transfer fluid. It was founded in 1992 and is headquartered in Beit Shemesh, IL. | Director of Finance/CFO | 01/09/2005 |
Formation de Chaime Orlev
| The College of Management Academic Studies | Undergraduate Degree |
| The Leon Recanati Graduate School of Business Administration | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ICTS INTERNATIONAL N.V. | Transportation |
| ORAMED PHARMACEUTICALS INC. | Health Technology |
| KAMADA LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Health Technology |
Huntleigh USA Corp.
 Huntleigh USA Corp. Miscellaneous Commercial ServicesCommercial Services Huntleigh USA Corp. provides security solutions for individuals and businesses. The firm offers active site monitoring, advanced technology solutions, video surveillance-as-a service, professional security and aviation & related services. It provides limited security services, such as charter flight and cargo screening, for airlines, as well as skycap, agent and special service personnel. The company was founded in 1992 and is headquartered in Irving, TX. | Commercial Services |
Solel Solar Systems Ltd.
Solel Solar Systems Ltd. Engineering & ConstructionIndustrial Services Solel Solar Systems Ltd. provides solar thermal power services. It designs, manufactures and installs turnkey solar fields for large scale power generation. It offers technology for new solar power plants in the US, Spain and other sun-rich locations. Solel's technology converts sunshine into useful thermal energy, and subsequently into electricity, by way of parabolic mirrors that concentrate the solar energy onto solar thermal receivers containing a heat transfer fluid. It was founded in 1992 and is headquartered in Beit Shemesh, IL. | Industrial Services |
